6533b859fe1ef96bd12b77cd
RESEARCH PRODUCT
Immunogenicity of TNF alpha inhibitors in rheumatology: many questions, enough answers?
Xavier GuillotFrank VerhoevenClément PratiDaniel Wendlingsubject
030203 arthritis & rheumatology0301 basic medicinemedicine.medical_specialtyTumor Necrosis Factor-alphabusiness.industryImmunologic FactorsImmunogenicityGeneral MedicineRheumatologyDrug levelsAntirheumatic Agents03 medical and health sciences030104 developmental biology0302 clinical medicineAntirheumatic AgentsRheumatic DiseasesInternal medicineImmunologyHumansImmunologic FactorsMedicinePharmacology (medical)Anti-TNF therapyTumor necrosis factor alphabusinessyear | journal | country | edition | language |
---|---|---|---|---|
2016-10-16 | Expert Opinion on Drug Safety |